OPPORTUNITY: Master Thesis in our labs
Would you like to develop your Master Thesis in the Nanobiotechnology for Diagnostics (Nb4D) research group? With us, you will have the chance of acquiring relevant expertise in the field of immunochemistry, in one of our projects: Antibodies for therapeutic applications. In this project, you will explore the potential value of monoclonal antibodies against infectious diseases caused by Pseudomonas aeruginosa by[...]
New article published in ACS infectious diseases!
Part of the research performed in the group during the last years pursuing the development of novel diagnostic techniques for bacterial infectious diseases has resulted in a new accepted paper: Direct Quantitative Immunochemical Analysis of the Autoinducer Peptide IV (AIP-IV) for Diagnosing and Stratifying Staphylococcus aureus infections.This work has been performed in collaboration with the group of Dr. Miriam Royo[...]
New project awarded in collaboration with IDIBAPS
The Carlos III Health Institute, in its call Proyectos de Desarrollo Tecnológico en Salud, has resolved to fund the project PH-Care: Development and Validation of a point-of-care assay for the diagnosis and prognosis of portal hypertension.This project, coordinated by the researcher Jordi Gracia-Sancho, from the Liver Vascular Biology group of IDIBAPS Biomedical Research Institute, counts on the participation of M.-Pilar[...]
Nb4D researchers in the RSEQ biannual meeting
Our group head, M.-Pilar Marco, and the scientists J.-Pablo Salvador, Núria Pascual and Lluïsa Vilaplana, are attending to the biannual meeting of the Spanish Royal Society of Chemistry (Real Sociedad Española de Química, RSEQ), held in this XXXVIII edition in Granada (27th-30th June). Besides being an excellent chance for networking with prominent scientists working in chemistry-related disciplines, the senior[...]
